115 related articles for article (PubMed ID: 7494898)
1. A case study of cancer data set combinations for PCBs.
Vater ST; Velazquez SF; Cogliano VJ
Regul Toxicol Pharmacol; 1995 Aug; 22(1):2-10. PubMed ID: 7494898
[TBL] [Abstract][Full Text] [Related]
2. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
[TBL] [Abstract][Full Text] [Related]
3. Carcinogenicity of "non-dioxinlike" polychlorinated biphenyls.
Knerr S; Schrenk D
Crit Rev Toxicol; 2006 Oct; 36(9):663-94. PubMed ID: 17050081
[TBL] [Abstract][Full Text] [Related]
4. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
Gaylor DW
Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
[TBL] [Abstract][Full Text] [Related]
5. Development of an oral cancer slope factor for Aroclor 1268.
Warren DA; Kerger BD; Britt JK; James RC
Regul Toxicol Pharmacol; 2004 Aug; 40(1):42-53. PubMed ID: 15265605
[TBL] [Abstract][Full Text] [Related]
6. Reassessment of the carcinogenicity of polychlorinated biphenyls (PCBs).
Smith MA
J Toxicol Environ Health; 1997 Apr; 50(6):567-79. PubMed ID: 15279030
[TBL] [Abstract][Full Text] [Related]
7. Weight of evidence evaluation of potential human cancer risks from exposure to polychlorinated biphenyls: an update based on studies published since 2003.
Golden R; Kimbrough R
Crit Rev Toxicol; 2009; 39(4):299-331. PubMed ID: 19514916
[TBL] [Abstract][Full Text] [Related]
8. Potential human cancer risks from exposure to PCBs: a tale of two evaluations.
Golden R; Doull J; Waddell W; Mandel J
Crit Rev Toxicol; 2003; 33(5):543-80. PubMed ID: 14594106
[TBL] [Abstract][Full Text] [Related]
9. Chloroform mode of action: implications for cancer risk assessment.
Golden RJ; Holm SE; Robinson DE; Julkunen PH; Reese EA
Regul Toxicol Pharmacol; 1997 Oct; 26(2):142-55. PubMed ID: 9356278
[TBL] [Abstract][Full Text] [Related]
10. Understanding population and individual risk assessment: the case of polychlorinated biphenyls.
Shields PG
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):830-9. PubMed ID: 16702358
[TBL] [Abstract][Full Text] [Related]
11. Comparison of cancer slope factors using different statistical approaches.
Subramaniam RP; White P; Cogliano VJ
Risk Anal; 2006 Jun; 26(3):825-30. PubMed ID: 16834636
[TBL] [Abstract][Full Text] [Related]
12. Biological considerations for combining carcinogenicity data for quantitative risk assessment.
Vater ST; McGinnis PM; Schoeny RS; Velazquez SF
Regul Toxicol Pharmacol; 1993 Dec; 18(3):403-18. PubMed ID: 8128002
[TBL] [Abstract][Full Text] [Related]
13. A comparison of liver tumor diagnoses from seven PCB studies in rats.
Moore JA; Hardisty JF; Banas DA; Smith MA
Regul Toxicol Pharmacol; 1994 Dec; 20(3 Pt 1):362-70. PubMed ID: 7724839
[TBL] [Abstract][Full Text] [Related]
14. Interactive effects of three structurally different polychlorinated biphenyls in a rat liver tumor promotion bioassay.
Haag-Grönlund M; Johansson N; Fransson-Steen R; Hâkansson H; Scheu G; Wärngård L
Toxicol Appl Pharmacol; 1998 Sep; 152(1):153-65. PubMed ID: 9772211
[TBL] [Abstract][Full Text] [Related]
15. Prediction of the health effects of polychlorinated biphenyls (PCBs) and their metabolites using quantitative structure-activity relationship (QSAR).
Ruiz P; Faroon O; Moudgal CJ; Hansen H; De Rosa CT; Mumtaz M
Toxicol Lett; 2008 Sep; 181(1):53-65. PubMed ID: 18662755
[TBL] [Abstract][Full Text] [Related]
16. Methodological limitations may prevent the observation of non-Hodgkin's lymphoma in bioassays of polychlorinated biphenyls.
Strauss HS; Heiger-Bernays W
Toxicol Pathol; 2012 Oct; 40(7):995-1003. PubMed ID: 22552391
[TBL] [Abstract][Full Text] [Related]
17. A statistical test of compatibility of data sets to a common dose-response model.
Stiteler WM; Knauf LA; Hertzberg RC; Schoeny RS
Regul Toxicol Pharmacol; 1993 Dec; 18(3):392-402. PubMed ID: 8128001
[TBL] [Abstract][Full Text] [Related]
18. Quantitative analysis of liver GST-P foci promoted by a chemical mixture of hexachlorobenzene and PCB 126: implication of size-dependent cellular growth kinetics.
Lu Y; Lohitnavy M; Reddy M; Lohitnavy O; Eickman E; Ashley A; Gerjevic L; Xu Y; Conolly RB; Yang RS
Arch Toxicol; 2008 Feb; 82(2):103-16. PubMed ID: 17874069
[TBL] [Abstract][Full Text] [Related]
19. Cancer dose--response assessment for acrylonitrile based upon rodent brain tumor incidence: use of epidemiologic, mechanistic, and pharmacokinetic support for nonlinearity.
Kirman CR; Gargas ML; Marsh GM; Strother DE; Klaunig JE; Collins JJ; Deskin R
Regul Toxicol Pharmacol; 2005 Oct; 43(1):85-103. PubMed ID: 16099568
[TBL] [Abstract][Full Text] [Related]
20. A mechanism-based cancer risk assessment for 1,4-dichlorobenzene.
Butterworth BE; Aylward LL; Hays SM
Regul Toxicol Pharmacol; 2007 Nov; 49(2):138-48. PubMed ID: 17688981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
